[1] Shang L, Shao M, Guo Q, et al. (2020) Diabetes mellitus is associated with severe infection and mortality in patients with COVID-19: a systematic review and meta-analysis. Archives of medical research 51(7): 700-709
[2] Gupta A, Madhavan MV, Sehgal K, et al. (2020) Extrapulmonary manifestations of COVID-19. Nature Medicine 26(7): 1017-1032
[3] Rubino F, Amiel SA, Zimmet P, et al. (2020) New-onset diabetes in Covid-19. New England Journal of Medicine 383(8): 789-790
[4] Muniangi-Muhitu H, Akalestou E, Salem V, Misra S, Oliver NS, Rutter GA (2020) Covid-19 and Diabetes: A Complex Bidirectional Relationship. Frontiers in Endocrinology 11: 758
[5] Mantovani A, Byrne CD, Zheng M-H, Targher G (2020) Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies. Nutrition, Metabolism and Cardiovascular Diseases 30(8): 1236-1248
[6] Hussain S, Baxi H, Jamali MC, Nisar N, Hussain MS (2020) Burden of diabetes mellitus and its impact on COVID-19 patients: a meta-analysis of real-world evidence. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14(6): 1595-1602
[7] Figliozzi S, Masci PG, Ahmadi N, et al. (2020) Predictors of adverse prognosis in COVID‐19: a systematic review and meta‐analysis. European journal of clinical investigation 50(10): e13362
[8] Aggarwal G, Lippi G, Lavie CJ, Henry BM, Sanchis-Gomar F (2020) Diabetes mellitus association with coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. J Diabetes 12(11): 851-855. 10.1111/1753-0407.13091
[9] Lee MH, Wong C, Ng CH, Yuen DC, Lim AY, Khoo CM (2021) Effects of hyperglycaemia on complications of COVID‐19: A meta‐analysis of observational studies. Diabetes, Obesity and Metabolism 23(1): 287-289
[10] Fu EL, Janse RJ, de Jong Y, et al. (2020) Acute kidney injury and kidney replacement therapy in COVID-19: a systematic review and meta-analysis. Clinical kidney journal 13(4): 550-563
[11] Piazza G, Campia U, Hurwitz S, et al. (2020) Registry of arterial and venous thromboembolic complications in patients with COVID-19. Journal of the American College of Cardiology 76(18): 2060-2072
[12] Rubino F, Amiel SA, Zimmet P, et al. (2020) New-Onset Diabetes in Covid-19. N Engl J Med 383(8): 789-790. 10.1056/NEJMc2018688
[13] Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A (2020) COVID-19 infection may cause ketosis and ketoacidosis. Diabetes, Obesity and Metabolism 22(10): 1935-1941. https://doi.org/10.1111/dom.14057
[14] Muller JA, Gross R, Conzelmann C, et al. (2021) SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab 3(2): 149-165. 10.1038/s42255-021-00347-110.1038/s42255-021-00347-1 [pii]
[15] Liu F, Long X, Zhang B, Zhang W, Chen X, Zhang Z (2020) ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clinical Gastroenterology and Hepatology 18(9): 2128-2130. e2122
[16] Fignani D, Licata G, Brusco N, et al. (2020) SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic β-cells and in the human pancreas microvasculature. Frontiers in Endocrinology 11: 876
[17] Capua I, Mercalli A, Pizzuto MS, et al. (2013) Influenza A viruses grow in human pancreatic cells and cause pancreatitis and diabetes in an animal model. J Virol 87(1): 597-610. 10.1128/JVI.00714-12JVI.00714-12 [pii]
[18] Capua I, Mercalli A, Romero-Tejeda A, et al. (2018) Study of 2009 H1N1 Pandemic Influenza Virus as a Possible Causative Agent of Diabetes. J Clin Endocrinol Metab 103(12): 4343-4356. 10.1210/jc.2018-008625091458 [pii]
[19] Accili D (2021) Can COVID-19 cause diabetes? Nat Metab 3(2): 123-125. 10.1038/s42255-020-00339-710.1038/s42255-020-00339-7 [pii]
[20] Ciceri F, Castagna A, Rovere-Querini P, et al. (2020) Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy. Clin Immunol 217: 108509. S1521-6616(20)30456-3 [pii]10.1016/j.clim.2020.108509
[21] Secchi M, Bazzigaluppi E, Brigatti C, et al. (2020) COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. J Clin Invest 130(12): 6366-6378. 10.1172/JCI142804142804 [pii]
[22] Bastard P, Rosen LB, Zhang Q, et al. (2020) Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370(6515). eabd4585 [pii]10.1126/science.abd4585 science.abd4585 [pii]
[23] Sathish T, Tapp RJ, Cooper ME, Zimmet P (2020) Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab: 101204. S1262-3636(20)30155-5 [pii] 10.1016/j.diabet.2020.10.002